Brain Cancer section

Brain Cancer News and Features

Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events

Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events

Radiotherapy of the brain is a mainstay of brain tumor treatment; however, it affects structural network properties in the brain and can cause cortical atrophy.

Spherical Shape of New Drug Holds Promise for Bypassing the Blood Brain Barrier and Treating Aggressive Brain Cancer

Spherical Shape of New Drug Holds Promise for Bypassing the Blood Brain Barrier and Treating Aggressive Brain Cancer

An investigational drug with a novel spherical nucleic acid structure has the potential to cross the blood-brain barrier to treat glioblastoma multiforme.

Cognitively Engaging Activities Often Discontinued After Treatment of Primary Brain Tumors

Cognitively Engaging Activities Often Discontinued After Treatment of Primary Brain Tumors

Survivors of primary brain tumors tend to freely discontinue cognitively engaging activities to compensate for diminishing cognitive function after treatment completion.

Research Shows Temozolomide Has Potential to Increase Depression

Research Shows Temozolomide Has Potential to Increase Depression

Temozolomide, an antimitotic chemotherapy used to treat brain cancer, demonstrated the potential to increase depression in a mouse model.

Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy

Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy

Deviation from radiation treatment protocol in young children being treated for brain neoplasms was associated with decreased overall survival.

Brain Cancer Clinical Trials

More Patients Enrolled in Cancer Trials Under ACA

Insurer approval rates rose from 85 percent before Affordable Care Act to 95 percent after the health care bill was enacted.

Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics

An analysis of rates at certain milestones in clinical trials of treatments for mNSCLC suggests these rates reflect end point results for immunotherapies vs targeted and conventional therapies.

Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer

Results of a phase 2 clinical trial of savolitinib, a highly selective small molecule inhibitor of c-Met, found the agent was active and tolerable in patients with Met-driven advanced or metastatic papillary renal cell carcinoma (PRCC).

Clinical Trials May Benefit Oncology Patients

Research on the effects of research demonstrated that oncology-related clinical trials provide measurable benefits in terms

Older Patients Under-Represented in Cancer Drug Clinical Trials

Older adults are underrepresented in clinical trials of cancer drugs, according to study findings presented at the 2017 ASCO Annual Meeting.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs